Drug intelligence / Profile preview

naproxen + histidine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

**Naproxen + histidine** is a combination product that contains the nonsteroidal anti-inflammatory drug (NSAID) naproxen and the amino acid histidine as oral tablets or kits intended for human use[1]. Naproxen is a well-known NSAID used for its analgesic, anti-inflammatory, and antipyretic properties, primarily for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis, and musculoskeletal pain[2]. The addition of histidine, a nutrient and potential buffer, to naproxen may aim to modify the product’s physical properties, possibly affecting stability, absorption, or tolerability, although specific pharmacological synergy or clinical benefit from the histidine component has not been documented in the available medical literature[1]. **Mechanism of action:** Naproxen works by non-selectively inhibiting cyclooxygenase (COX) enzymes, COX-1 and COX-2, thereby reducing the synthesis of prostaglandins, mediators of pain, inflammation, and fever[2]. COX-2 inhibition is mainly responsible for the anti-inflammatory effects, while COX-1 inhibition is associated with gastrointestinal side effects such as ulceration and bleeding[2]. The role of histidine in this combination is unclear from available sources—histidine is a natural amino acid, but its inclusion in this medicinal product is likely not for a direct pharmacological effect but rather for formulation purposes. **Primary indications:** As per the label for naproxen as a single agent, it is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and musculoskeletal pain[1][2]. There is no evidence of additional indications specific to the naproxen + histidine combination beyond those of naproxen alone.

Brand names
Trepoxen-250Trepoxen250Trepoxen 250
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on naproxen + histidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naproxen + histidine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call